BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28549688)

  • 1. Fibrodysplasia ossificans progressiva: The patient voice.
    Cali IL; Rossano L
    Bone; 2018 Apr; 109():291-294. PubMed ID: 28549688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrodysplasia ossificans progressiva in China.
    She D; Zhang K
    Bone; 2018 Apr; 109():101-103. PubMed ID: 29175272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
    Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
    J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum osteocalcin level is associated with the mortality in Chinese patients with Fibrodysplasia ossificans progressiva aged ≤18 years at diagnosis.
    She D; Li R; Fang P; Zong G; Xue Y; Zhang K
    BMC Musculoskelet Disord; 2020 Mar; 21(1):152. PubMed ID: 32143615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization.
    Pignolo RJ; Hsiao EC; Baujat G; Lapidus D; Sherman A; Kaplan FS
    Orphanet J Rare Dis; 2021 Aug; 16(1):350. PubMed ID: 34353327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva.
    Wentworth KL; Bigay K; Chan TV; Ho JP; Morales BM; Connor J; Brooks E; Shahriar Salamat M; Sanchez HC; Wool G; Pignolo RJ; Kaplan FS; Hsiao EC
    Bone; 2018 Apr; 109():104-110. PubMed ID: 29033382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP).
    Lindborg CM; Brennan TA; Wang H; Kaplan FS; Pignolo RJ
    Bone; 2018 Apr; 109():153-157. PubMed ID: 28963080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
    de Ruiter RD; Smilde BJ; Pals G; Bravenboer N; Knaus P; Schoenmaker T; Botman E; Sánchez-Duffhues G; Pacifici M; Pignolo RJ; Shore EM; van Egmond M; Van Oosterwyck H; Kaplan FS; Hsiao EC; Yu PB; Bocciardi R; De Cunto CL; Longo Ribeiro Delai P; de Vries TJ; Hilderbrandt S; Jaspers RT; Keen R; Koolwijk P; Morhart R; Netelenbos JC; Rustemeyer T; Scott C; Stockklausner C; Ten Dijke P; Triffit J; Ventura F; Ravazzolo R; Micha D; Eekhoff EMW
    Front Endocrinol (Lausanne); 2021; 12():732728. PubMed ID: 34858325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrodysplasia ossificans progressiva: Review and research activities in Japan.
    Haga N; Nakashima Y; Kitoh H; Kamizono J; Katagiri T; Saijo H; Tsukamoto S; Shinoda Y; Sawada R; Nakahara Y
    Pediatr Int; 2020 Jan; 62(1):3-13. PubMed ID: 31774601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrodysplasia ossificans progressiva in Brazil: challenges and strategies to create assistance and educational networks.
    Zorzi AR; Delai PR; Rosa HLC; Brito WE; Montalli VAM; Napimoga JC; Napimoga MH; Nociti FH
    Orphanet J Rare Dis; 2022 Sep; 17(1):348. PubMed ID: 36071499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis ossificans in children: a review.
    Sferopoulos NK; Kotakidou R; Petropoulos AS
    Eur J Orthop Surg Traumatol; 2017 May; 27(4):491-502. PubMed ID: 28275867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP).
    Kaplan FS; Al Mukaddam M; Pignolo RJ
    Bone; 2017 Aug; 101():123-128. PubMed ID: 28465250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomalignant heterotopic ossification.
    Kaplan FS; Gannon FH; Hahn GV; Wollner N; Prauner R
    Clin Orthop Relat Res; 1998 Jan; (346):134-40. PubMed ID: 9577421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint-specific risk of impaired function in fibrodysplasia ossificans progressiva (FOP).
    Pignolo RJ; Durbin-Johnson BP; Rocke DM; Kaplan FS
    Bone; 2018 Apr; 109():124-133. PubMed ID: 28627475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent.
    Upadhyay J; Xie L; Huang L; Das N; Stewart RC; Lyon MC; Palmer K; Rajamani S; Graul C; Lobo M; Wellman TJ; Soares EJ; Silva MD; Hesterman J; Wang L; Wen X; Qian X; Nannuru K; Idone V; Murphy AJ; Economides AN; Hatsell SJ
    J Bone Miner Res; 2017 Dec; 32(12):2489-2499. PubMed ID: 28782882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
    J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP).
    Hsiao EC; Di Rocco M; Cali A; Zasloff M; Al Mukaddam M; Pignolo RJ; Grunwald Z; Netelenbos C; Keen R; Baujat G; Brown MA; Cho TJ; De Cunto C; Delai P; Haga N; Morhart R; Scott C; Zhang K; Diecidue RJ; Friedman CS; Kaplan FS; Eekhoff EMW
    Br J Clin Pharmacol; 2019 Jun; 85(6):1199-1207. PubMed ID: 30281842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FOP Connection Registry: Design of an international patient-sponsored registry for Fibrodysplasia Ossificans Progressiva.
    Mantick N; Bachman E; Baujat G; Brown M; Collins O; De Cunto C; Delai P; Eekhoff M; Zum Felde R; Grogan DR; Haga N; Hsiao E; Kantanie S; Kaplan F; Keen R; Milosevic J; Morhart R; Pignolo R; Qian X; di Rocco M; Scott C; Sherman A; Wallace M; Williams N; Zhang K; Bogard B
    Bone; 2018 Apr; 109():285-290. PubMed ID: 28866367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.
    Ravazzolo R; Cappato S; Bocciardi R
    Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases.
    Kaplan FS; Zeitlin L; Dunn SP; Benor S; Hagin D; Al Mukaddam M; Pignolo RJ
    Bone; 2018 Apr; 109():281-284. PubMed ID: 29241828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.